Artificial Blood Tests Good Sign for European Approvals

Webb, Marion
September 2000
San Diego Business Journal;09/18/2000, Vol. 21 Issue 38, p10
Reports on developments related to biotechnology industries in San Diego, California as of May 26, 2000. Alliance Pharmaceutical Corp.'s announcement of the results from a large-stage trial of its artificial blood substitute Oxygent; Losses incurred by Illumina Inc. for the second quarter ending June 30, 2000.


Related Articles

  • Biotech receives Venture capital funding.  // San Diego Business Journal;01/17/2000, Vol. 21 Issue 3, p10 

    Announces the private equity funding received by San Diego, California-based biotechnology firm Illumina Inc. to speed up the development of its gene-identifying technology.

  • Many biotechs poised for development stage. Youmans, Sabrina // San Diego Business Journal;8/29/94, Vol. 15 Issue 35, p21 

    Reports on developments in San Diego, Calif.'s biotechnology industries. Companies' focus on product development; Increase in number of research and development staff; Phases of product development; Research and development stage; Clinical trials; Manufacturing; Profiles of Genta Inc. and...

  • Alliance Lays Off 35, Reports Quarterly Loss.  // San Diego Business Journal;11/25/2002, Vol. 23 Issue 47, p12 

    Reports on the financial results of San Diego, California biotech firm Alliance Pharmaceutical Corp. in the first quarter of 2002. Net loss; Dismissal of employees.

  • Execs: U.S. Should Follow Europe's Approach OK'ing New Biologics. Weeks, Katie // San Diego Business Journal;7/17/2006, Vol. 27 Issue 29, p15 

    The article presents news concerning the biotechnology industry in the United States. A survey showed that 44 percent of biotech executives believe that the U.S. should follow the European approach for approving generic biologics. Chief executive officer Duane Roth stated that Alliance...

  • `Burn rates' have some biotechs sweating hard. Fikes, Bradley J. // San Diego Business Journal;8/29/94, Vol. 15 Issue 35, p17 

    Focuses on the expected crisis in San Diego, Calif.'s biotechnology industry. Definition of the term `burn rate'; Initial public offerings in 1994; Fluctuating values of stock prices; Two strategies for companies wishing to survive the crisis; Merger with a bigger company; Creative financing;...

  • One from the heart. Webb, Marion // San Diego Business Journal;06/14/99, Vol. 20 Issue 24, p8 

    Profiles Duane Roth, chairman and chief executive officer of San Diego, California-based biotechnology firm Alliance Pharmaceutical Corp. Personal and professional background; Civic involvement.

  • BIOTECHNOLOGY COMPANIES.  // San Diego Business Journal;6/23/2014, Vol. 35 Issue 25, p40 

    A chart is presented which ranks the top biotechnology companies in California based on the number of local employees as of July 1, 2013 including Illumina Inc., Genentech Inc., and Halozyme Therapeutics.

  • BIOTECH. Webb, Marion // San Diego Business Journal;09/04/2000, Vol. 21 Issue 36, p4 

    Presents news from the biotechnology industry in San Diego, California as of September 2000. Alliance Pharmaceutical Corp.'s ultrasound contrast agent, Imagent; Discovery Partners International Inc.; Nanogen Inc.

  • Biotechs Create Jobs Along With Innovations. Glidden, Stephanie R. // San Diego Business Journal;2/20/2012, Vol. 33 Issue 8, p3 

    The article reports on the "San Diego Business Journal's" list of Biotechnology Companies for 2012 which is ranked based on the number of local employees as of October 1, 2011 including Illumina Inc., Optimer Pharmaceuticals Inc., and Verenium Corp.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics